• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CNST

CNST

Constellation Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD33.99

+0.00 (+0.00%)

Company Profile

CEO

Jigar Raythatha

IPO Date

2018-07-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$33.98

Prev. Close

$33.99

Day Low

$33.97

Day High

$34.03

52W Low

$17.00

52W High

$39.30

Volume

1.27M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

18.8%

Avg Negative

5.0%

Avg Neutral

76.4%

News Feed

Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib

GlobeNewsWire·6/11/2021·↑ positive

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Constellation Pharmaceuticals, Inc. - CNST

PRNewsWire·6/4/2021·↓ negative

Why Constellation Pharmaceuticals Stock Was Crushing It This Week

The Motley Fool·6/3/2021
·↑ positive

Why Constellation Pharmaceuticals Stock Is Skyrocketing Today

The Motley Fool·6/2/2021·↓ negative

Shareholder Alert: Ademi LLP investigates whether Constellation Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with MorphoSys

PRNewsWire·6/2/2021·↓ negative

Constellation Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Constellation Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – CNST

Business Wire·6/2/2021·↓ negative

Why Constellation Pharmaceuticals Is Soaring Today

Benzinga·6/2/2021·↑ positive

CNST Stock Price: Over 60% Increase Pre-Market Explanation

Pulse2·6/2/2021·↑ positive

Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

GlobeNewsWire·5/31/2021·↑ positive

Constellation Pharmaceuticals, Inc. (CNST) CEO Jigar Raythatha on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/10/2021·↓ negative